SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $347,000 | -84.9% | 60,000 | -84.2% | 0.00% | -83.3% |
| Q1 2016 | $2,297,000 | +23.3% | 379,727 | +86.8% | 0.01% | +20.0% |
| Q4 2015 | $1,863,000 | +57.7% | 203,259 | -1.6% | 0.01% | +66.7% |
| Q3 2015 | $1,181,000 | +788.0% | 206,517 | +5041.1% | 0.00% | – |
| Q2 2015 | $133,000 | -98.6% | 4,017 | -99.3% | 0.00% | -100.0% |
| Q1 2015 | $9,741,000 | -0.7% | 563,797 | 0.0% | 0.02% | -4.2% |
| Q4 2014 | $9,807,000 | +53.1% | 563,797 | +4.3% | 0.02% | +50.0% |
| Q3 2014 | $6,405,000 | -29.4% | 540,380 | +0.3% | 0.02% | -27.3% |
| Q2 2014 | $9,066,000 | +25.4% | 538,880 | +34.7% | 0.02% | +15.8% |
| Q1 2014 | $7,232,000 | -38.6% | 400,000 | -52.8% | 0.02% | -40.6% |
| Q4 2013 | $11,772,000 | +32.5% | 847,550 | 0.0% | 0.03% | +23.1% |
| Q3 2013 | $8,882,000 | +168.0% | 847,550 | +99.7% | 0.03% | +160.0% |
| Q2 2013 | $3,314,000 | – | 424,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |